Related references
Note: Only part of the references are listed.Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies
Nader S. Abutaleb et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Ana Rakita et al.
SCIENTIFIC REPORTS (2020)
Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections
Nader S. Abutaleb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery
Claudiu T. Supuran
EXPERT OPINION ON DRUG DISCOVERY (2020)
Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities
Hassan E. Eldesouky et al.
SCIENTIFIC REPORTS (2020)
Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus
Jatinder Kaur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Antibacterial carbonic anhydrase inhibitors: an update on the recent literature
Claudiu T. Supuran et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Antibacterial and antivirulence activities of auranofin against Clostridium difficile
Ahmed AbdelKhalek et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Battle against Vancomycin-Resistant Bacteria: Recent Developments in Chemical Strategies
Geetika Dhanda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
Navaneeth Narayanan et al.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2019)
The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens
Dimitra Repana et al.
GENOME BIOLOGY (2019)
Anti-Helicobacter pylori activity of ethoxzolamide
Joyanta K. Modak et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
In vivo and in vitro effects of a ClpP activating antibiotic against vancomycin resistant enterococci
Autumn Brown Gandt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci
Haroon Mohammad et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
Ahmed AbdelKhalek et al.
SCIENTIFIC REPORTS (2018)
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Tao Zuo et al.
FRONTIERS IN MICROBIOLOGY (2018)
Epidemiology, Associated Conditions, and Outcomes of Hospital Associated Vancomycin-Resistant Enterococcus Infections in the US Military Health Care System
David Stagliano et al.
Open Forum Infectious Diseases (2017)
In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens
Waleed Younis et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia
Nicholas S. Britt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M)
S. Fiedler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Structure and function of carbonic anhydrases
Claudiu T. Supuran
BIOCHEMICAL JOURNAL (2016)
Linezolid Toxicity and Mitochondrial Susceptibility: A Novel Neurological Complication in a Lebanese Patient
Ossama K. Abou Hassan et al.
FRONTIERS IN PHARMACOLOGY (2016)
The Carbonic Anhydrase Inhibitor Ethoxzolamide Inhibits the Mycobacterium tuberculosis PhoPR Regulon and Esx-1 Secretion and Attenuates Virulence
Benjamin K. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association
Larry M. Baddour et al.
CIRCULATION (2015)
Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience
James A. McKinnell et al.
CLINICAL INFECTIOUS DISEASES (2015)
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
David Brown
NATURE REVIEWS DRUG DISCOVERY (2015)
An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model
Haroon Mohammad et al.
PLOS ONE (2015)
Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal Strains
Francois Lebreton et al.
MBIO (2013)
Intrinsic and acquired resistance mechanisms in enterococcus
Brian L. Hollenbeck et al.
VIRULENCE (2012)
Enterococcus faecalis Metalloprotease Compromises Epithelial Barrier and Contributes to Intestinal Inflammation
Natalie Steck et al.
GASTROENTEROLOGY (2011)
Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?
Claudiu T. Supuran
FRONTIERS IN PHARMACOLOGY (2011)
Management of multidrug-resistant enterococcal infections
C. A. Arias et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans
Caries Ubeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
Leonard A. Mermel et al.
CLINICAL INFECTIOUS DISEASES (2009)
Carbonic anhydrase inhibitors:: The β-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors
Isao Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Quinupristin-dalfopristin resistance in Enterococcus faecium isolates from humans, farm animals, and grocery store meat in the United States
S. M. Donabedian et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Carbonic anhydrase inhibitors:: DNA cloning and inhibition studies of the α-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs
I Nishimori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings
P Beringer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection
LS Munoz-Price et al.
CLINICAL INFECTIOUS DISEASES (2005)
Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomvcin-resistant enterococci and extended- spectrum-β-lactamase-producing Klebsiella pneumoniae in mice
NJ Pultz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin
MT Wong et al.
CLINICAL INFECTIOUS DISEASES (2001)
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
RD Gonzales et al.
LANCET (2001)
Aminoglycoside resistance in enterococci
JW Chow
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
